1.34
0.00 (0.00%)
| Penutupan Terdahulu | 1.34 |
| Buka | 1.33 |
| Jumlah Dagangan | 1,326,657 |
| Purata Dagangan (3B) | 3,443,830 |
| Modal Pasaran | 996,348,224 |
| Harga / Jualan (P/S) | 1.77 |
| Harga / Buku (P/B) | 0.840 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 28 Oct 2026 |
| Margin Keuntungan | -5.66% |
| Margin Operasi (TTM) | -44.79% |
| EPS Cair (TTM) | -0.060 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -13.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 37.58% |
| Nisbah Semasa (MRQ) | 2.49 |
| Aliran Tunai Operasi (OCF TTM) | -182.48 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -107.74 M |
| Pulangan Atas Aset (ROA TTM) | -8.20% |
| Pulangan Atas Ekuiti (ROE TTM) | -3.04% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | Opko Health, Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | 2.0 |
| Purata | -0.50 |
|
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 46.81% |
| % Dimiliki oleh Institusi | 30.94% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Whitefort Capital Management, Lp | 31 Mar 2026 | 4,253,340 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| LOGAL ADAM | - | 1.22 | -53,266 | -64,985 |
| RUBIN STEVEN D | - | 1.22 | -53,266 | -64,985 |
| Jumlah Keseluruhan Kuantiti Bersih | -106,532 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -129,969 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 1.22 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| RUBIN STEVEN D | Pegawai | 24 Jul 2026 | Dibuang (-) | 53,266 | 1.22 | 64,985 |
| LOGAL ADAM | Pegawai | 24 Jul 2026 | Dibuang (-) | 53,266 | 1.22 | 64,985 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |